Related Experiment Video
Updated: Aug 9, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Decentralized testing for prothrombin time and activated partial thromboplastin time using a dry chemistry portable
V L Rose1, S C Dermott, B F Murray
1Center for Thrombosis and Hemostasis, University of North Carolina, Chapel Hill.
This study validates a portable dry chemistry system for blood coagulation analysis in decentralized hospital settings. The system demonstrated acceptable accuracy for prothrombin time and activated partial thromboplastin time testing, offering a viable alternative to central laboratories.
Area of Science:
- Clinical Chemistry
- Point-of-Care Testing
- Medical Diagnostics
Background:
- Previous research confirmed the accuracy of a portable blood coagulation analysis system.
- Decentralized testing in hospital settings requires validated, reliable methods.
Purpose of the Study:
- To evaluate the deployment and performance of a portable dry chemistry coagulation system in various hospital locations.
- To compare results from the portable system with a central laboratory for key coagulation parameters.
Main Methods:
- Nursing staff were trained to operate the portable system at the point of care (surgical ICU, CCU, cardiology clinic).
- Coagulation tests (prothrombin time, activated partial thromboplastin time) were performed on patient samples using the dry chemistry system and compared to central laboratory results.
- Quality control measures were implemented, including daily testing by laboratory staff.
Main Results:
- The portable dry chemistry system showed acceptable correlation coefficients with the central laboratory across multiple sites, users, and instruments.
- Testing was conducted over an extended period, involving different reagent lots and equipment.
- Results were consistent despite variations in testing locations and personnel.
Conclusions:
- The portable dry chemistry system is a suitable alternative to central laboratory testing for prothrombin time and activated partial thromboplastin time.
- Appropriate training and robust quality assurance are crucial for successful implementation.
- This technology enhances decentralized blood coagulation analysis capabilities in clinical settings.
More Related Videos
08:50Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis
Published on: January 9, 2026
08:01The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
Published on: February 27, 2026